-
-
-
-
-
-
-
Climb Bio to present kidney disease data at ASN 2026 conference
-
-
-
-
-
-
-
Verastem presents LGSOC drug data at IGCS 2026 meeting
-
-
-
-
-
-
-
Regeneron drug shows muscle preservation in GLP-1 weight loss trial
-
-
-
-
-
-
-
PolyPid regains European rights to D-PLEX100 after ADVANZ deal ends
-
-
-
-
-
-
-
Aktis Oncology starts second phase 1b trial for AKY-2519 in lung cancer
-
-
-
-
-
-
-
Novo Nordisk Wegovy data shows liver fat reduction in obesity trial
-
-
-
-
-
-
-
Lilly's EloraTZP shows greater weight loss than tirzepatide in Phase 2b trial
-
77,318 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

